|
1
|
GBD 2021 Global Sepsis Collaborators.
Global, Regional, and national sepsis incidence and mortality,
1990-2021: A systematic analysis. Lancet Global Health.
13:e2013–e2026. 2025.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gottlieb M, Wusterbarth E, Hlavin R,
Bernard K and Moyer E: Epidemiology of sepsis presentations and
management among United States emergency departments from 2016 to
2023. Acad Emerg Med. 32:467–470. 2025.PubMed/NCBI View Article : Google Scholar
|
|
3
|
La Via L, Sangiorgio G, Stefani S, Marino
A, Nunnari G, Cocuzza S, La Mantia I, Cacopardo B, Stracquadanio S,
Spampinato S, et al: The global burden of sepsis and septic shock.
Epidemiologia (Basel). 5:456–478. 2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Guo Y, An B, Lang Z, Zhou F, Zhang X and
Wang H: Effects of curcumin on inhibiting the proliferation of
pulmonary artery smooth muscle cells and relieving pulmonary
arterial hypertension. Farmacia. 68:307–312. 2020.
|
|
5
|
Vella R, Panci D, Carini F, Malta G, Vieni
S, David S, Albano GD, Puntarello M, Zerbo S and Argo A: Cytokines
in sepsis: A critical review of the literature on systemic
inflammation and multiple organ dysfunction. Front Immunol.
16(1682306)2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li LL, Dai B, Sun YH and Zhang TT: The
activation of IL-17 signaling pathway promotes pyroptosis in
pneumonia-induced sepsis. Ann Transl Med. 8(674)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sherwood ER, Burelbach KR, McBride MA,
Stothers CL, Owen AM, Hernandez A, Patil NK, Williams DL and
Bohannon JK: Innate immune memory and the host response to
infection. J Immunol. 208:785–792. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chan JK, Roth J, Oppenheim JJ, Tracey KJ,
Vogl T and Feldmann M: Alarmins: Awaiting a clinical response. J
Clin Invest. 122:2711–2719. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Jin H, Aziz M, Murao A, Kobritz M, Shih AJ
and Adelson RP: Antigen-presenting aged neutrophils induce CD4+ T
cells to exacerbate inflammation in sepsis. J Clin Invest.
133(e164585)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen Z, Zhang H, Qu M, Nan K, Cao H and
Cata JP: Review: The emerging role of neutrophil extracellular
traps in sepsis and Sepsis-associated thrombosis. Front Cell Infect
Microbiol. 11(653228)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang H, Kim SJ, Lei Y, Wang S, Wang H,
Huang H, Zhang H and Tsung A: Neutrophil extracellular traps in
homeostasis and disease. Sig Transduct Target Ther.
9(235)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Denning NL, Aziz M, Gurien SD and Wang P:
Damps and nets in sepsis. Front Immunol. 10(2536)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Weng W, Hu Z and Pan Y: Macrophage
extracellular traps: Current opinions and the state of research
regarding various diseases. J Immunol Res.
2022(7050807)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Delabranche X, Stiel L, Severac F, Galoisy
AC, Mauvieux L and Zobairi F: Evidence of netosis in septic
shock-induced disseminated intravascular coagulation. Shock.
47:313–317. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sahu SK, Kulkarni DH, Ozanturk AN, Ma L
and Kulkarni HS: Emerging roles of the complement system in
host-pathogen interactions. Trends in Microbiol. 30:390–402.
2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Jayaraman A, Walachowski S and Bosmann M:
The complement system: A key player in the host response to
infections. Eur J Immunol. 54(2350814)2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Abe T, Kubo K, Izumoto S, Shimazu S, Goan
A and Tanaka T: Complement activation in human sepsis is related to
Sepsis-induced disseminated intravascular coagulation. Shock.
54:198–204. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cavaillon JM: During sepsis and COVID-19,
the pro-inflammatory and anti-inflammatory responses are
concomitant. Clin Rev Allerg Immu. 65:183–187. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sommerfeld O, Medyukhina A, Neugebauer S,
Ghait M, Ulferts S, Lupp A, König R, Wetzker R, Schulz S, Figge MT,
et al: Targeting complement C5a Receptor 1 for the treatment of
immunosuppression in sepsis. Mol Ther. 29:338–346. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Levi M and van der Poll T: Coagulation and
sepsis. Thromb Res. 149:38–44. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Iba T, Watanabe E, Umemura Y, Wada T,
Hayashida K and Kushimoto S: Japanese Surviving Sepsis Campaign
Guideline Working Group for disseminated intravascular coagulation.
Wada H: Sepsis-associated disseminated intravascular coagulation
and its differential diagnoses. J Intensive Care.
7(32)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Engelmann B and Massberg S: Thrombosis as
an intravascular effector of innate immunity. Nat Rev Immunol.
13:34–45. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Perdomo J and Leung HH: Immune thrombosis:
Exploring the significance of immune complexes and NETosis. Biology
(Basel). 12(1332)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
de Stoppelaar SF, van't Veer C and van der
Poll T: The role of platelets in sepsis. Thromb Haemost.
112:666–677. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
McDonald B, Davis RP, Kim SJ, Tse M, Esmon
CT, Kolaczkowska E and Jenne CN: Platelets and neutrophil
extracellular traps collaborate to promote intravascular
coagulation during sepsis in mice. Blood. 129:1357–1367.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Keragala CB, Draxler DF, McQuilten ZK and
Medcalf RL: Haemostasis and innate immunity-a complementary
relationship: A review of the intricate relationship between
coagulation and complement pathways. Br J Haematol. 180:782–798.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Silasi-Mansat R, Zhu H, Popescu NI, Peer
G, Sfyroera G, Magotti P, Ivanciu L, Lupu C, Mollnes TE, Taylor FB,
et al: Complement inhibition decreases the procoagulant response
and confers organ protection in a baboon model of Escherichia
coli sepsis. Blood. 116:1002–1010. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tsuchiya K: Inflammasome-associated cell
death: Pyroptosis, apoptosis, and physiological implications.
Microbiol Immunol. 64:252–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bahari S, Zeighami H, Mirshahabi H,
Roudashti S and Haghi F: Inhibition of Pseudomonas aeruginosa
quorum sensing by subinhibitory concentrations of curcumin with
gentamicin and azithromycin. J Glob Antimicrob Resist. 10:21–28.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Newcomb D, Bolgos G, Green L and Remick
DG: Antibiotic treatment influences outcome in murine sepsis.
Shock. 10:110–117. 1998.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Allegra A, Mirabile G, Ettari R, Pioggia G
and Gangemi S: The impact of curcumin on immune response: An
immunomodulatory strategy to treat sepsis. Int J Mol Sci.
23(14710)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mimche PN, Taramelli D and Vivas L: The
plant-based immunomodulator curcumin as a potential candidate for
the development of an adjunctive therapy for cerebral malaria.
Malar J. 10 (Suppl 1)(S10)2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jentzer JC, Coons JC, Link CB and
Schmidhofer M: Pharmacotherapy update on the use of vasopressors
and inotropes in the intensive care unit. J Cardiovasc Pharmacol
Ther. 20:249–260. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Anjusha S and Gangaprasad A: Phytochemical
and antibacterial analysis of two important curcuma species,
Curcuma aromatica salisb. and Curcuma xanthorrhiza
roxb. (Zingiberaceae). J Pharmacognosy Phytochemistry. 3:50–53.
2014.
|
|
35
|
Kuptniratsaikul V, Dajpratham P,
Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P,
Chootip C, Saengsuwan J, Tantayakom K and Laongpech S: Efficacy and
safety of Curcuma domestica extracts compared with ibuprofen
in patients with knee osteoarthritis: A multicenter study. Clin
Interv Aging. 9:451–458. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Maheshwari RK, Singh AK, Gaddipati J and
Srimal RC: Multiple biological activities of curcumin: A short
review. Life Sci. 78:2081–2087. 2006.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ammon H and Wahl M: Pharmacology of
Curcuma longa. Planta Med. 57:1–7. 1991.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Pan MH, Huang TM and Lin JK:
Biotransformation of curcumin through reduction and glucuronidation
in mice. Drug Metab Dispos. 27:486–494. 1999.PubMed/NCBI
|
|
39
|
Holder GM, Plummer JL and Ryan AJ: The
metabolism and excretion of curcumin
(1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,s-dione) in
the rat. Xenobiotica. 8:761–768. 1978.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Basnet P and Skalko-Basnet N: Curcumin: An
anti-inflammatory molecule from a curry spice on the path to cancer
treatment. Molecules. 16:4567–4598. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hewlings SJ and Kalman DS: Curcumin: A
review of its effects on human health. Foods. 6(92)2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Srivastava R, Dikshit M, Srimal RC and
Dhawan BN: Antithrombotic effect of curcumin. Thromb Res.
40:413–417. 1985.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hanai H and Sugimoto K: Curcumin has
bright prospects for the treatment of inflammatory bowel disease.
Curr Pharm Des. 15:2087–2094. 2009.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang J, Wang H, Zhu R, Liu Q, Fei J and
Wang S: Anti-inflammatory activity of curcumin-loaded solid lipid
nanoparticles in IL-1β transgenic mice subjected to the
lipopolysaccharide-induced sepsis. Biomaterials. 53:475–483.
2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Liu JY, Lin SJ and Lin JK: Inhibitory
effects of curcumin on protein kinase C activity induced by
12-0-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells.
Carcinogenesis. 14:857–861. 1993.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen H and Huang H: Effect of curcumin on
cell cycle progression and apoptosis in vascular smooth muscle
cells. Br J Pharmacol. 124:1029–1040. 1998.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang F, Altorki NK, Mestre JR,
Subbaramaiah K and Dannenberg AJ: Curcumin inhibits
cyclooxygenase-2 transcription in bile acid- and phorbol
ester-treated human gastrointestinal epithelial cells.
Carcinogenesis. 20:445–451. 1999.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Reddy S and Aggarwal BB: Curcumin is a
non-competitive and selective inhibitor of phosphorylase kinase.
FEBS Lett. 341:19–22. 1994.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Sidhu GS, Singh AK, Thaloor D, Banaudha
KK, Patnaik GK, Srimal RC and Maheshwari RK: Enhancement of wound
healing by curcumin in animals. Wound Repair Regen. 6:167–177.
1998.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Niranjan A, Singh S, Dhiman M and Tewari
SK: Biochemical composition of Curcuma longa L. accessions.
Anal Lett. 46:1069–1083. 2012.
|
|
51
|
Priyadarsini K: The chemistry of curcumin:
From extraction to therapeutic agent. Molecules. 19:20091–20112.
2014.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Workman P and Collins I: Probing the
probes: Fitness factors for small molecule tools. Chem Biol.
17:561–577. 2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Nelson KM, Dahlin JL, Bisson J, Graham J,
Pauli GF and Walters MA: The essential medicinal chemistry of
curcumin. J Med Chem. 60:1620–1637. 2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Parcha V, Kumar P, Farswan M and Maithani
A: Individual and combined effect of aqueous extract of Gymnema
sylvestre, Tinospora cordifolia and Piper longum on carrageenan
induced inflamed rats. Indian Drugs. 47:65–67. 2010.
|
|
55
|
Barua N and Buragohain AK: Therapeutic
potential of curcumin as an antimycobacterial agent. Biomolecules.
11(1278)2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Thi Sinh Vo, Vo Tran Thi Bich Chau, Tran
Thi Thu Ngoc Vo and Thi Ngoc Huyen Lai: Turmeric (Curcuma
longa L.): Chemical components and their effective clinical
applications. JOTCSA Chemistry. 8:883–898. 2021.
|
|
57
|
Ahmad RS, Hussain MB, Sultan MT, Arshad M,
Waheed M, Shariati MA, Plygun S and Hashempur MH: Biochemistry,
safety, pharmacological activities, and clinical applications of
turmeric: A mechanistic review. Evid Based Complement Alternat Med.
2020(7656919)2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Peter AE, Sandeep BV, Rao BG and Kalpana
VL: Calming the storm: Natural immunosuppressants as adjuvants to
target the cytokine storm in COVID-19. Front Pharmacol.
11(583777)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Xu F, Lin SH, Yang YZ, Guo R, Cao J and
Liu Q: The effect of curcumin on sepsis-induced acute lung injury
in a rat model through the inhibition of the TGF-β1/SMAD3 pathway.
Int Immunopharmacol. 16:1–6. 2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Vacek JC, Behera J, George AK, Kamat PK,
Kalani A and Tyagi N: Tetrahydrocurcumin ameliorates
homocysteine-mediated mitochondrial remodeling in brain endothelial
cells. J Cell Physiol. 233:3080–3092. 2018.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Hu W, Cai M, Qi D, Ying X, Huang C and
Xing C: β-Ionone-derived curcumin analogs as potent
anti-inflammatory agents. Pharm Chem J. 51:902–906. 2018.
|
|
62
|
Zhang Y, Liu Z, Wu J, Bai B, Chen H, Xiao
Z, Chen L, Zhao Y, Lum H, Wang Y, et al: New MD2 inhibitors derived
from curcumin with improved anti-inflammatory activity. Eur J Med
Chem. 148:291–305. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Wu Y, Liu Z, Wu W, Lin S, Zhang N, Wang H,
Tan S, Lin P, Chen X, Wu L and Xu J: Effects of FM0807, a novel
curcumin derivative, on lipopolysaccharide-induced inflammatory
factor release via the ROS/JNK/p53 pathway in RAW264.7 cells.
Biosci Rep. 38(BSR20180849)2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Liu W, Guo W, Zhu Y, Peng S, Zheng W,
Zhang C, Shao F, Zhu Y, Hang N, Kong L, et al: Targeting
peroxiredoxin 1 by a curcumin analogue, AI-44, inhibits NLRP3
inflammasome activation and attenuates lipopolysaccharide-induced
sepsis in mice. J Immunol. 201:2403–2413. 2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Ahn MY, Hwang JS, Lee SB, Ham SA, Hur J,
Kim JT and Seo HG: Curcuma longa extract-loaded nanoemulsion
improves the survival of endotoxemic mice by inhibiting nitric
oxide-dependent HMGB1 release. PeerJ. 5(e3808)2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Zhong W, Qian K, Xiong J, Ma K, Wang A and
Zou Y: Curcumin alleviates lipopolysaccharide-induced sepsis and
liver failure by suppression of oxidative stress-related
inflammation via PI3K/AKT and NF-κB related signaling. Biomed
Pharmacother. 83:302–313. 2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Rana M, Maurya P, Reddy SS, Singh V, Ahmad
H, Dwivedi AK, Dikshit M and Barthwal MK: A standardized chemically
modified Curcuma longa extract modulates IRAK-MAPK signaling
in inflammation and potentiates cytotoxicity. Front Pharmacol.
7(223)2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Tham CL, Lam KW, Rajajendram R, Cheah YK,
Sulaiman MR, Lajis NH, Kim MK and Israf DA: The effects of a
synthetic curcuminoid analogue,
2,6-bis-(4-hydroxyl-3-methoxybenzylidine)cyclohexanone on
proinflammatory signaling pathways and CLP-induced lethal sepsis in
mice. Eur J Pharmacol. 652:136–144. 2011.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zhang Y, Liang D, Dong L, Ge X, Xu F, Chen
W, Dai Y, Li H, Zou P, Yang S and Liang G: Anti-inflammatory
effects of novel curcumin analogs in experimental acute lung
injury. Respir Res. 16(43)2015.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Gong Z, Zhou J, Li H, Gao Y, Xu C, Zhao S,
Chen Y, Cai W and Wu J: Curcumin suppresses NLRP3 inflammasome
activation and protects against LPS-induced septic shock. Mol Nutr
Food Res. 59:2132–2142. 2015.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Zhao C, Zhang Y, Zou P, Wang J, He W, Shi
D, Li H, Liang G and Yang S: Synthesis and biological evaluation of
a novel class of curcumin analogs as anti-inflammatory agents for
prevention and treatment of sepsis in mouse model. Drug Des Devel
Ther. 9:1663–1678. 2015.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Shukla P, Verma AK, Dewangan J, Rath SK
and Mishra PR: Chitosan coated curcumin nanocrystals augment
pharmacotherapy via improved pharmacokinetics and interplay of
NFκB, Keap1 and Nrf2 expression in Gram negative sepsis†. RSC Adv.
5:57006–57020. 2015.
|
|
73
|
Shukla P, Dwivedi P, Gupta PK and Mishra
PR: Optimization of novel tocopheryl acetate nanoemulsions for
parenteral delivery of curcumin for therapeutic intervention of
sepsis. Expert Opin Drug Deliv. 11:1697–1712. 2014.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zhang Y, Jiang X, Peng K, Chen C, Fu L,
Wang Z, Feng J, Liu Z, Zhang H, Liang G and Pan Z: Discovery and
evaluation of novel anti-inflammatory derivatives of natural
bioactive curcumin. Drug Des Devel Ther. 8:2161–2171.
2014.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Wu J, Zhang Y, Cai Y, Wang J, Weng B, Tang
Q, Chen X, Pan Z, Liang G and Yang S: Discovery and evaluation of
piperid-4-one-containing mono-carbonyl analogs of curcumin as
anti-inflammatory agents. Bioorg Med Chem. 21:3058–3065.
2013.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Sharifi S, Fathi N, Memar MY, Hosseiniyan
Khatibi SM, Khalilov R, Negahdari R, Zununi Vahed S and Maleki
Dizaj S: Anti-microbial activity of curcumin nanoformulations: New
trends and future perspectives. Phytother Res. 34:1926–1946.
2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Ali Raza Naqvi S, Nadeem S, Komal S, Naqvi
A, Samee Mubarik M, Yaqub Qureshi S, Ahmad S, Zahid M, Khan
Naeem-Ul-Haq, Raza SS and Aslam N: Antioxidants: Natural
antibiotics. In: Antioxidants. IntechOpen, 2019.
|
|
78
|
Pandit RS, Gaikwad SC, Agarkar GA, Gade AK
and Rai M: Curcumin nanoparticles: Physico-chemical fabrication and
its in vitro efficacy against human pathogens. 3 Biotech.
5:991–997. 2015.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Martins CVB, da Silva DL, Neres ATM,
Magalhães TFF, Watanabe GA, Modolo LV, Sabino AA, de Fátima A and
de Resende MA: Curcumin as a promising antifungal of clinical
interest. J Antimicrob Chemother. 63:337–339. 2009.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Hettiarachchi SS, Perera Y, Dunuweera SP,
Dunuweera AN, Rajapakse S and Rajapakse RMG: Comparison of
antibacterial activity of nanocurcumin with bulk curcumin. ACS
Omega. 7:46494–46500. 2022.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Tyagi P, Singh M, Kumari H, Kumari A and
Mukhopadhyay K: Bactericidal activity of curcumin I is associated
with damaging of bacterial membrane. PLoS One.
10(e0121313)2015.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Song J, Choi B, Jin EJ, Yoon Y and Choi
KH: Curcumin suppresses Streptococcus mutans adherence to human
tooth surfaces and extracellular matrix proteins. Eur J Clin
Microbiol Infect Dis. 31:1347–1352. 2012.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Betts JW and Wareham DW: In vitro activity
of curcumin in combination with epigallocatechin gallate (EGCG)
versus multidrug-resistant Acinetobacter baumannii. BMC Microbiol.
14(172)2014.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Mun SH, Joung DK, Kim YS, Kang OH, Kim SB,
Seo YS, Kim YC, Lee DS, Shin DW, Kweon KT and Kwon DY: Synergistic
antibacterial effect of curcumin against methicillin-resistant
Staphylococcus aureus. Phytomedicine. 20:714–718.
2013.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Izui S, Sekine S, Maeda K, Kuboniwa M,
Takada A and Amano A: Antibacterial activity of curcumin against
periodontopathic bacteria. J Periodontol. 87:83–90. 2016.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Wang J, Zhou X, Li W, Deng X, Deng Y and
Niu X: Curcumin protects mice from Staphylococcus aureus
pneumonia by interfering with the self-assembly process of
α-hemolysin. Sci Rep. 6(28254)2016.PubMed/NCBI View Article : Google Scholar
|
|
87
|
De R, Kundu P, Swarnakar S, Ramamurthy T,
Chowdhury A, Nair GB and Mukhopadhyay AK: Antimicrobial activity of
curcumin against Helicobacter pylori isolates from India and during
infections in mice. Antimicrob Agents Chemother. 53:1592–1597.
2009.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Yun DG and Lee DG: Antibacterial activity
of curcumin via apoptosis-like response in Escherichia coli.
Appl Microbiol Biotechnol. 100:5505–5514. 2016.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Amol Marathe S, Balakrishnan A, Devi Negi
V, Sakorey D, Chandra N and Chakravortty D: Curcumin reduces the
motility of Salmonella enterica serovar Typhimurium by binding to
the flagella, thereby leading to flagellar fragility and shedding.
J Bacteriol. 198:1798–1811. 2016.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Bellio P, Brisdelli F, Perilli M, Sabatini
A, Bottoni C, Segatore B, Setacci D, Amicosante G and Celenza G:
Curcumin inhibits the SOS response induced by levofloxacin in
Escherichia coli. Phytomedicine. 21:430–434. 2014.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Zhang J, Tang L, Li GS and Wang J: The
anti-inflammatory effects of curcumin on renal ischemia-reperfusion
injury in rats. Renal Failure. 40:680–686. 2018.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Huang W, Li X, Wang D, Sun Y, Wang Q, Bu Y
and Niu F: Curcumin reduces LPS-induced septic acute kidney injury
through suppression of lncRNA PVT1 in mice. Life Sci.
254(117340)2020.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Fan Y, Chen H, Peng H, Huang F, Zhong J
and Zhou J: Molecular mechanisms of curcumin renoprotection in
experimental acute renal injury. Front Pharmacol.
8(912)2017.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Li L, Liu X, Li S, Wang Q, Wang H, Xu M
and An Y: Tetrahydrocurcumin protects against sepsis-induced acute
kidney injury via the SIRT1 pathway. Renal Failure. 43:1028–1040.
2021.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Maa F, Liu F, Ding L, You M, Yue H and
Zhou Y: Anti-inflammatory effects of curcumin are associated with
down regulating microRNA-155 in LPS-treated macrophages and mice.
Pharm Biol. 55:1263–1278. 2017.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Vachharajani V, Wang SW, Mishra N, el
Gazzar M, Yoza B and McCall C: Curcumin modulates leukocyte and
platelet adhesion in murine sepsis. Microcirculation. 17:407–416.
2010.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Kumari A, Dash D and Singh R: Curcumin
inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway
inflammation through modulation of sequential release of
inflammatory mediators (TNF-α and TGF-β1) in murine model.
Inflammopharmacology. 25:329–341. 2017.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Liu YF, Yang CW, Liu H, Sui SG and Li XD:
Efficacy and therapeutic potential of curcumin against
sepsis-induced chronic lung injury in male albino rats. J Nutr
Health Aging. 21:307–313. 2017.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Memis D, Hekimoglu S, Sezer A, Altaner S,
Sut N and Usta U: Curcumin attenuates the organ dysfunction caused
by endotoxemia in the rat. Nutrition. 24:1133–1138. 2008.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Lukita-Atmadja W, Ito Y, Baker GL and
McCuskey RS: Effect of curcuminoids as anti-inflammatory agents on
the hepatic microvascular response to endotoxin. Shock. 17:399–403.
2002.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Luo DD, Chen JF, Liu JJ, Xie JH, Zhang ZB,
Gu JY, Zhuo JY, Huang S, Su ZR and Sun ZH: Tetrahydrocurcumin and
octahydrocurcumin, the primary and final hydrogenated metabolites
of curcumin, possess superior hepatic-protective effect against
acetaminophen-induced liver injury: Role of CYP2E1 and Keap1-Nrf2
pathway. Food Chem Toxicol. 123:349–362. 2019.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Qiu F, Zeng C, Liu Y, Pan H and Ke C: J147
ameliorates sepsis-induced depressive-like behaviors in mice by
attenuating neuroinflammation through regulating the TLR4/NF-κB
signaling pathway. J Mol Histol. 54:725–738. 2023.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Gaddipati JP, Sundar SV, Calemine J, Seth
P, Sidhu GS and Maheshwari RK: Differential regulation of cytokines
and transcription factors in liver by curcumin following
hemorrhage/resuscitation. Shock. 19:150–156. 2003.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Shan B, Schaaf C, Schmidt A, Lucia K,
Buchfelder M, Losa M, Kuhlen D, Kreutzer J, Perone MJ, Arzt E, et
al: Curcumin suppresses HIF1A synthesis and VEGFA release in
pituitary adenomas. J Endocrinol. 214:389–398. 2012.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Zhao M, Wang Y, Yue Y, Zhang R, Wang S and
Zhang W: Curcumin alleviates neuronal apoptosis and cerebral
mitochondrial dysfunction in septic mice. Int. J Clin Exp Med.
9:6107–6113. 2016.
|
|
106
|
Wang Y, Shan X, Dai Y, Jiang L, Chen G,
Zhang Y, Wang Z, Dong L, Wu J, Guo G and Liang G: Curcumin analog
L48H37 prevents lipopolysaccharide-induced TLR4 signaling pathway
activation and sepsis via targeting MD2. J Pharmacol Exp Ther.
353:539–550. 2015.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Yang C, Wu K, Li SH and You Q: Protective
effect of curcumin against cardiac dysfunction in sepsis rats.
Pharm Biol. 51:482–487. 2013.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Zhu H, Zhang L, Jia H, Xu L, Cao Y, Zhai
M, Li K, Xia L, Jiang L, Li X, et al: Tetrahydrocurcumin improves
lipopolysaccharide-induced myocardial dysfunction by inhibiting
oxidative stress and inflammation via JNK/ERK signaling pathway
regulation. Phytomedicine. 104(154283)2022.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Rattis BAC, Piva HL, Duarte A, Gomes
FGFLR, Lellis JR, Soave DF, Ramos SG, Tedesco AC and Celes MRN:
Modulation of the mTOR pathway by curcumin in the heart of septic
mice. Pharmaceutics. 14(2277)2022.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Olszanecki R, Gebska A and Korbut R: The
role of haem oxygenase-1 in the decrease of endothelial
intercellular adhesion molecule-1 expression by curcumin. Basic
Clin Pharmacol Toxicol. 101:411–415. 2007.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Kumari A, Tyagi N, Dash D and Singh R:
Intranasal curcumin ameliorates lipopolysaccharide-induced acute
lung injury in mice. Inflammation. 38:1103–1112. 2015.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Carter Y, Liu G, Yang J, Fier A and Mendez
C: Sublethal hemorrhage induces tolerance in animals exposed to
cecal ligation and puncture by altering p38, p44/42, and SAPK/JNK
MAP kinase activation. Surg Infect (Larchmt). 4:17–27.
2003.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Yuan Z, Syed MA, Panchal D, Rogers D, Joo
M and Sadikot RT: Curcumin mediated epigenetic modulation inhibits
TREM-1 expression in response to lipopolysaccharide. Int J Biochem
Cell Biol. 44:2032–2043. 2012.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Sompamit K, Kukongviriyapan U, Nakmareong
S, Pannangpetch P and Kukongviriyapan V: Curcumin improves vascular
function and alleviates oxidative stress in non-lethal
lipopolysaccharide-induced endotoxaemia in mice. Eur J Pharmacol.
616:192–199. 2009.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Lu W, Jiang JP, Hu J, Wang J and Zheng MZ:
Curcumin protects against lipopolysaccharide-induced
vasoconstriction dysfunction via inhibition of thrombospondin-1 and
transforming growth factor-β1. Exp Ther Med. 9:377–383.
2015.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Chen L, Lu Y, Zhao L, Hu L, Qiu Q, Zhang
Z, Li M, Hong G, Wu B, Zhao G and Lu Z: Curcumin attenuates
sepsis-induced acute organ dysfunction by preventing inflammation
and enhancing the suppressive function of Tregs. Int
Immunopharmacol. 61:1–7. 2018.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Silva LS, Catalão CH, Felippotti TT,
Oliveira-Pelegrin GR, Petenusci S, de Freitas LA and Rocha MJ:
Curcumin suppresses inflammatory cytokines and heat shock protein
70 release and improves metabolic parameters during experimental
sepsis. Pharm Biol. 55:269–276. 2017.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Hu G, Wang D, Jiang L, Xu L, Zhao L and
Zhou M: Curcumin protects hepatocytes from sepsis by regulating
inflammatory response and hepatocyte apoptosis. Trop J Pharm Res.
21:67–71. 2022.
|
|
119
|
Yun SS, Kim SP, Kang MY and Nam SH:
Inhibitory effect of curcumin on liver injury in a murine model of
endotoxemic shock. Biotechnol Lett. 32:209–214. 2010.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Gradišar H, Keber MM, Pristovšek P and
Jerala R: MD-2 as the target of curcumin in the inhibition of
response to LPS. J Leukoc Biol. 82:968–974. 2007.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Chen HW, Kuo HT, Chai CY, Ou JL and Yang
RC: Pretreatment of curcumin attenuates coagulopathy and renal
injury in LPS-induced endotoxemia. J Endotoxin Res. 13:15–23.
2007.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Zhu H, Wang X, Wang X, Liu B, Yuan Y and
Zuo X: Curcumin attenuates inflammation and cell apoptosis through
regulating NF-κB and JAK2/STAT3 signaling pathway against acute
kidney injury. Cell Cycle. 19:1941–1951. 2020.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Wang S, Zhao P, Zhang Y, Zhu L, Zhu J, Luo
Y and Li Q: The therapeutic effects of curcumin in early septic
acute kidney injury: An experimental study. Drug Des Devel Ther.
15:4243–4255. 2021.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Xiao X, Yang M, Sun D and Sun S: Curcumin
protects against sepsis-induced acute lung injury in rats. J Surg
Res. 176:e31–e39. 2012.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Yılmaz Savcun G, Ozkan E, Dulundu E,
Topaloğlu U, Sehirli AO, Tok OE, Ercan F and Sener G: Antioxidant
and anti-inflammatory effects of curcumin against hepatorenal
oxidative injury in the experimental sepsis model created in rats.
Ulus Travma Acil Cerrahi Derg. 19:507–515. 2013.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Alexa ID, Ilie AC, Prada G, Herghelegiu
AM, Luca A and Rotaru TŞ: A comprehensive behavioural assessment of
curcumin's effect on inflammatory and non-inflammatory pain in
mice. Farmacia. 68:829–834. 2020.
|
|
127
|
Singla V, Mouli VP, Garg SK, Rai T,
Choudhury BN, Verma P, Deb R, Tiwari V, Rohatgi S, Dhingra R, et
al: Induction with NCB-02 (curcumin) enema for mild-to-moderate
distal ulcerative colitis-A randomized, placebo-controlled, pilot
study. J Crohns Colitis. 8:208–214. 2013.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Laurindo LF, De Carvalho GM, De Oliveira
Zanuso B, Figueira ME, Direito R, de Alvares Goulart R, Buglio DS
and Barbalho SM: Curcumin-based nanomedicines in the treatment of
inflammatory and immunomodulated diseases: An evidence-based
comprehensive review. Pharmaceutics. 15(229)2023.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Stohs SJ, Chen O, Ray SD, Ji J, Bucci LR
and Preuss HG: Highly bioavailable forms of curcumin and promising
avenues for curcumin-based research and application: A review.
Molecules. 25(1397)2020.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Roney M and Mohd Aluwi MFF: Unraveling the
systems biology of curcumin: A Mini-review of its Anti-diabetic
potential through network pharmacology. Cell Biochem Biophys: Sep
10, 2025 doi: 10.1007/s12013-025-01888-y (Epub ahead of print).
|
|
131
|
Wahnou H, El Kebbaj R, Liagre B, Sol V,
Limami Y and Duval RE: Curcumin-based nanoparticles: Advancements
and challenges in tumor therapy. Pharmaceutics.
17(114)2025.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Xiang DB, Zhang KQ, Zeng YL, Yan QZ, Shi
Z, Tuo QH, Lin LM, Xia BH, Wu P and Liao DF: Curcumin: From a
controversial ‘panacea’ to effective antineoplastic products.
Medicine (Baltimore). 99(e18467)2020.PubMed/NCBI View Article : Google Scholar
|
